Jae S. Cho, M.D

Form 483 issued December 31, 2025

Inspection
Dec 17 – Dec 31, 2025
Observations
2
Pages
3
FEI number
3040335429

In short: On December 31, 2025, FDA issued a Form 483 with 2 observations to Jae S. Cho, M.D (FEI 3040335429) after an inspection that ran Dec 17 – Dec 31, 2025. The investigator was Brittany M. Kershaw. Most observations concern clinical (BIMO); the most-cited regulation is 21 CFR 812.100 (general responsibilities of investigators).

At a glance

2 of 2 observations on this 483 concern clinical (bimo).

Clinical (BIMO)2

Most cited: 21 CFR 812.100 (1×) · 50.27 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01
    21 CFR 812.100

    An investigation was not conducted according…

  2. 02

    Informed consent was not properly documented in that the written informed consent used in the study…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Jae S. Cho, M.D?

FDA listed 2 observations on this Form 483, mostly about clinical (BIMO). The most-cited regulation is 21 CFR 812.100 (general responsibilities of investigators). The opening words of each observation are shown on this page.

Who inspected Jae S. Cho, M.D?

Brittany M. Kershaw is named on this Form 483, for the inspection of Dec 17 – Dec 31, 2025. Each investigator has a profile showing what they cite most.

When was Jae S. Cho, M.D inspected by FDA?

The inspection ran Dec 17 – Dec 31, 2025, and the Form 483 is dated December 31, 2025.

How do I get the full Form 483 for Jae S. Cho, M.D?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free